Value of screening umbilical cord blood for hemoglobinopathy

Foremost among the beneficial effects of screening umbilical cord blood is the optimized quality of care that can follow the immediate involvement of an infant with sickle cell disease and his or her family in an appropriate health care system. This is exemplified by the reduction in the case fatali...

Full description

Saved in:
Bibliographic Details
Published in:Pediatrics (Evanston) 1989-05, Vol.83 (5 Pt 2), p.823-826
Main Authors: Lobel, J S, Cameron, B F, Johnson, E, Smith, D, Kalinyak, K
Format: Article
Language:English
Subjects:
Anemia, Sickle Cell - blood
Anemia, Sickle Cell - epidemiology
Anemia, Sickle Cell - mortality
Fetal Blood - analysis
Hemoglobin SC Disease - blood
Hemoglobin, Sickle - analysis
Humans
Infant, Newborn
Mass Screening
Ohio
Sickle Cell Trait - blood
Thalassemia - blood
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Foremost among the beneficial effects of screening umbilical cord blood is the optimized quality of care that can follow the immediate involvement of an infant with sickle cell disease and his or her family in an appropriate health care system. This is exemplified by the reduction in the case fatality rate of pneumococcal septicemia that has been achieved. Appropriate follow-up of screening also includes transmission of information about the diagnosis of a hemoglobinopathy trait or alpha-thalassemia to affected families and their physicians, with ready availability of education and counseling.
ISSN:0031-4005
1098-4275
DOI:10.1542/peds.83.5.823